An unusual cause of a necrotic bullous skin lesion: a case report.

Swiss Med WklySep 25, 2026 (epub)

Katharina Knapp, Stephanie Holzer, Marius Schlienger

✦ AI-curated · Sources linked

Case in brief

A man in his 30s presented with a necrotic bullous lesion on his right palm and ipsilateral lymphadenopathy after contact with a hare carcass in Canada. Initial treatment with a cephalosporin was ineffective. PCR confirmed tularaemia, leading to a switch to ciprofloxacin after doxycycline was discontinued due to side effects. The lesion and symptoms resolved rapidly with ciprofloxacin.

What made this case unusual

The case illustrates ulceroglandular tularaemia presenting as a necrotic bullous skin lesion, which is atypical and highlights the need for awareness of this zoonotic infection in returning travelers.

Diagnostic / clinical pearl

Clinicians should consider tularaemia in patients with necrotic skin lesions and lymphadenopathy, especially following exposure to potential zoonotic sources.

Why it matters

This case underscores the importance of a detailed exposure history and the need for appropriate diagnostic testing when standard treatments fail.

Source

Published in Swiss Med Wkly. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.